Invasive breast cancers overexpressing cyclin D1 are predominantly oestrogen receptor (OR)-positive, whereas cyclin E high tumours in contrast are OR-negative and often p27 low as well as p53- and pRb-inactivated (Nielsen et al, 1999; Loden et al, 2002). This evidence concerns the gene CCND1 and breast cancer.